Corcept Therapeutics, Inc. (CORT)
56.37
-1.93
(-3.31%)
USD |
NASDAQ |
May 15, 16:00
56.40
+0.02
(+0.04%)
After-Hours: 20:00
Corcept Therapeutics Market Cap : 6.051B for May 15, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 275.09B |
| Supernus Pharmaceuticals, Inc. | 2.869B |
| Terns Pharmaceuticals, Inc. (DELISTED) | 6.111B |
| Assertio Holdings, Inc. | 149.64M |
| Nektar Therapeutics | 1.222B |
Market Cap Related Metrics
| PE Ratio | 161.06 |
| PS Ratio | 8.506 |
| Price to Book Value | 9.485 |
| Price to Free Cash Flow | 54.61 |
| Price | 56.37 |
| Earnings Yield | 0.62% |
| Normalized PE Ratio | 161.06 |